Price Change

#GILD (Gilead Sciences, Inc.). Exchange rate and online charts.

#GE Return to the list of instruments #GOOG

Currency converter

EUR

USD

104.33 USD
30 Apr 2025 18:16

$0
(0%)

Prev Close

$91.6

Open

$92.43

Day's High

$92.76

Day's Low

$91.72

Week High

$92.76

Week Low

$89.1

Download archive

Open the chart in full screen view

Download archive

Open the chart in full screen view

Gilead Sciences, Inc.

Gilead Sciences is a US biopharmaceutical company specialized in the development of drugs. The corporation was established in 1987 as an organization involved in the creation of medicine against AIDS, hepatitis, influenza, and some lung diseases. Later, the company began developing medications to treat oncological diseases.

Monitor the price dynamic of Gilead Sciences, Inc. stocks and earn using online charts and analysis articles provided by InstaTrade.

Company’s history

In 1987, Michael Riordan, a novice and unknown pharmacist at that time, founded Gilead Sciences, Inc., a pharmaceutical company. Michael Riordan set himself the aim to create an effective drug against viruses. It was not an accidental choice of the field of research. A year earlier, he suffered from dengue fever, a complex viral disease. The corporation founded by Michael Riordan quickly grew, merging with other American pharmaceutical groups and laboratories. That was Gilead Sciences that created Sovaldi, the most expensive drug in the US used to treat hepatitis C.

Today, Gilead Sciences, Inc. employs about 3,500 people. Despite the fact that the company is quite old and really successful, it brought its shares to the market only in 2013. In winter 2019, the share price reached its highest level of $70.05.

How to buy shares of Gilead Sciences, Inc.

We will help you to purchase shares of Gilead Sciences, Inc. Monitor the price chart, read analytical articles from the leading economists, and trade with InstaTrade.

Open an account and make a deposit.
Choose the instrument in the trading platform and bet on the rise or fall in the share price.

Shares of Gilead Sciences is a promising trading instrument as the company is constantly creating and issuing new drugs, investing its profit into long-term development.